Article | Open | Published:

Catalytic mechanism and molecular engineering of quinolone biosynthesis in dioxygenase AsqJ

Nature Communicationsvolume 9, Article number: 1168 (2018) | Download Citation

Abstract

The recently discovered FeII/α-ketoglutarate-dependent dioxygenase AsqJ from Aspergillus nidulans stereoselectively catalyzes a multistep synthesis of quinolone alkaloids, natural products with significant biomedical applications. To probe molecular mechanisms of this elusive catalytic process, we combine here multi-scale quantum and classical molecular simulations with X-ray crystallography, and in vitro biochemical activity studies. We discover that methylation of the substrate is essential for the activity of AsqJ, establishing molecular strain that fine-tunes π-stacking interactions within the active site. To rationally engineer AsqJ for modified substrates, we amplify dispersive interactions within the active site. We demonstrate that the engineered enzyme has a drastically enhanced catalytic activity for non-methylated surrogates, confirming our computational data and resolved high-resolution X-ray structures at 1.55 Å resolution. Our combined findings provide crucial mechanistic understanding of the function of AsqJ and showcase how combination of computational and experimental data enables to rationally engineer enzymes.

Introduction

The non-heme FeII/α-ketoglutarate-dependent dioxygenase AsqJ from Aspergillus nidulans (Fig. 1a) is an exceptional enzyme that activates dioxygen and stereoselectively catalyzes a C–C bond desaturation and epoxidation reaction1,2. AsqJ converts its natural substrate, 4′-methoxycyclopeptin (1), to a quinolone alkaloid, 4′-methoxyviridicatin (4) (Fig. 1b). It is remarkable that a single enzyme can catalyze such large-scale chemical transformations in a one-pot multistep reaction. The characteristic 4-arylquinolin-2(1H)-one structure of 4 is found in a variety of quinolone alkaloids3,4,5, which are compounds with promising antibacterial and antitumor activities6. In addition to the central role of non-heme FeII/α-ketoglutarate-dependent oxygenases in many metabolic pathways7,8,9, elucidation of the catalytic mechanism of AsqJ is also important due to the promising application of different quinol alkaloids as potential drug candidates.

Fig. 1
Fig. 1

The structure and active site of AsqJ. a The dimeric protein structure of AsqJ (PDB ID:5DAQ; one subunit in the asymmetric unit), depicting the location of the active site. The inset shows a DFT model of the active site of AsqJ, comprising 194 atoms. Atoms marked with asterisk are kept fixed in the structure optimizations. b Reaction sequence catalyzed by AsqJ. Substrate 1 is the AsqK-produced NRPS product of anthranilic acid and Tyr(OMe); the N4-methyl group is derived from S-adenosylmethionine15

Watanabe and co-workers1 initially discovered AsqJ as the enzyme responsible for the biosynthesis of the quinolone alkaloid 4 in Aspergillus nidulans (Fig. 1). The crystal structure of the NiII-substituted AsqJ was recently resolved at 1.7 Å resolution, revealing the molecular architecture of the dioxygenase in presence of different reaction intermediates2. The active site of AsqJ forms a funnel like reaction chamber, located at the interface between antiparallel β-strands. The substrate interacts with the active site metal, which is ligated by His-211, His-134, Asp-136, as well as by the C-2 keto group and C-1 carboxylate of α-ketoglutarate (αKG), and a crystallographic water molecule in an octahedral coordination sphere. Moreover, His-134 forms a π-stacking interaction with the substrate that may further play an important role for the substrate binding and the catalytic activity.

Although the catalytic cycle of AsqJ has remained unclear, it was suggested that the enzyme generates a highly oxidizing ferryl species by splitting dioxygen, similar to many other non-heme iron enzymes10,11,12. AsqJ inserts one of the oxygen atoms into αKG, yielding succinate upon decarboxylation13. The resulting ferryl is further employed to catalyze desaturation of the C–C single bond, yielding the intermediate 4′-methoxydehydrocyclopeptin (2), characterized in high-performance liquid chromatography–mass spectrometry (HPLC/MS) experiments2. Recent experimental and computational studies14,15,16 also support that the high-spin ferryl, FeIV = O, intermediate could indeed be the catalytically active species. In subsequent steps of the reaction cycle, binding of a second oxygen molecule is likely to induce epoxidation of the double bond of 2 leading to formation of the epoxide 4′-methoxycyclopenin (3), which in turn undergoes a non-enzymatic re-arrangement and elimination reaction to form the final product 4 (Fig. 1b). Interestingly, it was also observed that AsqJ can effectively catalyze the desaturation reaction only when the substrate is methylated at the N4 position (see Supplementary Fig. 1 for substrate labeling), whereas upon removal of the N4-methyl group, the epoxide 3 was not formed2.

From an evolutionary perspective, this finding is in line with the N4-methylation activity of the non-ribosomal peptide synthetase (NRPS) AsqK producing 117. Nevertheless, from a chemical point of view this finding is unexpected, since the methyl group is located three bonds apart from the reacting atoms in the substrate.

In order to probe the catalytic mechanics of AsqJ and to rationally engineer an enzyme that can catalyze chemical transformations of non-methylated substrates, we employ here an integrated computational and experimental approach. We derive the energetics and molecular structures of putative catalytic intermediates from multi-scale quantum and classical molecular simulations, which can provide powerful methodologies to study structure, dynamics, and energetics of complex (bio)chemical reactions on a wide range of timescales and spatial resolutions18,19,20,21. The computational work is combined with site-directed mutagenesis experiments, in vitro activity measurements by HPLC/MS, and structural characterization by X-ray crystallography.

Results

Energetics and mechanism of AsqJ

In order to probe the energetics and structure of the reaction catalyzed by AsqJ for its natural substrate 1, we performed quantum chemical density functional theory (DFT) calculations on active site enzyme models of AsqJ (Fig. 1a, inset). The catalytic cycle of AsqJ is initiated by binding of dioxygen to the FeII active site. In order to accommodate O2, a crystallographic water molecule observed in the NiII-substituted structure was removed and the structures were re-optimized. The optimized structural model suggests that substitution of NiII with FeII results only in minor structural changes (Supplementary Fig. 2). The DFT free energies along the quintet pathway indicate that dioxygen binding is exergonic by ca. 23 kcal mol−1. Thus, formation of the ferric-superoxide species, FeIII–O2•/−, occurs spontaneously, similar as in many other iron enzymes (Fig. 2a, see Supplementary Figs. 6 and 7 for the triplet spin state)22,23. For the insertion of the oxygen atom into αKG, we obtain a barrier of ca. 7 kcal mol−1 with a transition state that has a peroxo-like character (Fig. 2a). For the subsequent decarboxylation step, a barrier of ca. 16 kcal mol−1 has to be overcome, for which the products CO2 and succinate are stabilized by hydrogen bonds with a crystallographic water molecule and Gln-131, respectively (Supplementary Fig. 3, 4). Moreover, the DFT calculations suggest that entropic effects do not considerably alter the reaction profiles, except for the oxygen binding and decarboxylation steps, for which we obtain TΔS contributions at T = 298 K of ca. 6 kcal mol−1 (destabilizing) and 4 kcal mol−1 (stabilizing), respectively (Fig. 2a, Supplementary Fig. 5a).

Fig. 2
Fig. 2

Calculated catalytic cycle and energetics of AsqJ. a The first part of the reaction cycle, comprising oxygen activation, decarboxylation of αKG, and two subsequent PCET reaction steps. b The second part of the reaction involving epoxidation of the substrate. All energies refer to free energies calculated in the quintet state at B3LYP-D3/def2-TZVP/ε = 4 level of theory with vibrational and entropic corrections at the B3LYP-D3/def2-SV(P)/ε = 4 level. Barriers are obtained from reaction pathway optimizations (Methods). See also Supplementary Movies 1 and 2, and Supplementary Figs. 3 and 9 for the optimized intermediate structures. Free energy profiles along the triplet surface are shown in Supplementary Figs. 6 and 7

The calculations suggest that the CO2 release could be coupled to a flip of the ferryl group towards the substrate, which also enables the reorientation of the CO2-stabilizing water molecule (Supplementary Movie 1). Notably, the achieved state is ca. 8 kcal mol−1 more favorable than the oxygen-inserted αKG state, and its configuration leads to an increase in the π-stacking interaction between the substrate and His-134, decreasing the distances between the groups from 3.7 Å to 3.5 Å. In the subsequent step, the oxidizing power of the ferryl is employed to thermodynamically drive two proton-coupled electron transfer (PCET) reactions, for which we obtain reaction barriers of ca. 16 kcal mol−1 and 9 kcal mol−1, for the first and second transfer reactions, respectively (Fig. 2a). The first PCET process results in a radical on C3 that delocalizes mainly on the C3–C2 bond (Supplementary Fig. 8a), whereas no significant spin density is observed on the proton during the transfer from C3 to the iron ligand. We therefore conclude that the proton and electron move along different reaction channels between the substrate and the redox-active metal (Supplementary Fig. 8b).

After the desaturation has taken place, the second part of the reaction cycle is initiated by binding of new αKG and O2 molecules, which lead to a similar decarboxylation and rotation of the oxo-ferryl bond, with a barrier of ca. 17 kcal mol−1 (Fig. 2b). We further find that the resulting ferryl species could attack the double bond with a barrier of 16 kcal mol−1, resulting in the subsequent formation of the epoxide and FeII (Fig. 2b, Supplementary Movie 2).

Taken together, the overall free energy profile is strongly exergonic, and the putative reactions have kinetically feasible barriers of ca. 7–17 kcal mol−1, which is consistent with the accumulation of the product on the seconds timescales in HPLC/MS experiments (see below). These barriers are also consistent with recent computational studies15,16, suggesting that the hydrogen abstraction and epoxidation reactions have barriers between 4 and 22 kcal mol−1.

Substrate methylation is central for catalysis

Next, we aimed to probe why AsqJ does not catalyze desaturation of the substrate analog lacking a methyl group at the N4 position. To this end we recalculated the reaction pathway with the non-methylated surrogate (Fig. 2, Supplementary Fig. 5, 9). Interestingly, we obtain similar energetics as for the natural substrate for most steps of the catalytic cycle. However, our computed binding affinities between the substrate and the protein, as well as the molecular strain energy stored within the substrates, suggest that there are significant differences between the N4-methylated and non-methylated educts (Table 1). We find that for the two PCET reactions, the methylated substrate undergoes marginal conformational changes around its C3–C1″–C1′–C2′ dihedral angle relative to its optimized structure in gas phase (Table 1, Supplementary Fig. 10). In stark contrast, for the non-methylated surrogate, we observe that the central C3–C1″–C1′–C2′ dihedral angle is twisted in the active site pocket by ca. 10–30° from its structure in gas phase (Table 1, Supplementary Fig. 10). According to the DFT calculations, these structural rearrangements introduces strain energy up to ca. 8 kcal mol−1 in the surrogate, which in turn weakens the π–π stacking interaction between the surrogate’s methoxy-phenyl group and His-134 (Table 1). This prediction is further supported by calculations of non-covalent interaction surfaces within the active site pocket (Fig. 3a), and it is also consistent with reduction in the binding affinities between the substrate and the active site during the PCET reactions (Table 1). These findings thus suggest that the stabilization of non-methylated surrogates in AsqJ is impaired during the PCET reactions.

Table 1 Binding affinities, strain energies, and dihedral angles (C3–C1″–C1′–C2′) for the substrates before and after the first and second PCET steps
Fig. 3
Fig. 3

Engineering AsqJ to catalyze turnover of modified surrogates. a Non-covalent interaction densities (purple surfaces) between His-134 and the methylated substrate/non-methylated surrogate for wt and V72I-mutant AsqJ prior to the first PCET reaction. b Snapshot from a QM/MM MD simulation of AsqJ. The QM region is shown in colored licorice and link atoms are depicted in purple, and Val-72 is shown in gray licorice. c The stacking distance (r) between His-134 (CD2) and the substrate (C1′) in presence of the methylated substrate and the non-methylated surrogate after the first PCET reaction. d The stacking distance (r) in presence of the methylated substrate and the non-methylated surrogate for wt and V72I-mutant AsqJ before the first PCET reaction. The simulations were performed using both QM/MM MD simulations (c) and classical atomistic MD simulations (d) to explore different timescales

We got interested in how this π-stacking interaction is influenced by the dynamics of the enzyme, and therefore performed hybrid quantum mechanics/classical mechanics (QM/MM) molecular dynamics (MD) simulations of the states with the native substrate and non-methylated surrogate after the initial PCET process. Consistent with the results from the DFT models, our computations reveal that the distance between the His-134 and the methoxy-phenyl ring of the substrate drastically increases from 3.4 to 4.0 Å from the native substrate to the non-methylated surrogate in the QM/MM MD simulations (Fig. 3b, c). Hence, our simulations support that the molecular strain within the non-methylated substrate might lead to its dissociation from the binding pocket during the PCET steps.

Engineering AsqJ to catalyze non-methylated surrogate

In the QM/MM MD trajectories, we observe that Val-72, located on a loop surrounding the substrate-binding pocket, forms dispersive interactions with the methoxy-phenyl of the ligand and His-134 (Fig. 3b). In order to strengthen the π–π interactions between the non-methylated surrogate and the protein, we replaced the Val-72 with a somewhat larger isoleucine residue, followed by new DFT calculations and classical MD simulations. Interestingly, the DFT models suggest that the V72I replacement indeed strengthens the interaction between the protein and the methoxy-phenyl ring of the non-methylated substrate analog prior to the first PCET reaction by decreasing the distances between the aromatic systems from 4.1 to 3.8 Å (Fig. 3a). The MD simulations also indicate an enhanced stabilization of the non-methylated surrogate in the active site of V72I mutant (Fig. 3c). For comparison, we also studied the effect of the V72K, V72L, and F139I substitutions to increase the interaction between His-134 and the substrate from the opposite side. However, whereas the V72K and V72L mutants did not improve the π-stacking interactions (Supplementary Fig. 12), the F139I variant showed some minor increase in the dispersive interactions between His-134 and the surrogate.

In our next approach, we probed the engineered enzyme experimentally. To this end, we cloned, expressed, and purified the V72I-, V72K-, and F139I-mutated AsqJ enzymes. The catalytic activities of these mutants were determined for the native substrate 1, cyclopeptine 1b (Supplementary Fig. 13b), as well as for demethylcyclopeptine 1d (Fig. 4) and compared to the wild-type (wt) AsqJ by using a reverse-phase HPLC/MS-coupled activity assay, and X-ray crystallography. The wt and V72I-, V72K-, F139I-mutated AsqJ variants turned out to have similar turnover rates for the methylated substrates 1 and 1b (Supplementary Fig. 13a, b), suggesting that these alterations do not lead to a significant decrease in the enzyme activity. In the following, we analyzed how the engineered enzymes affect the turnover of the non-methylated substrate analog 1d. Remarkably, the HPLC/MS activity assays depict that the desaturated reaction intermediate, 2d, which follows the two PCET reactions of 1d (Figs. 1b, 2a), is already formed at 20 s for V72I, in stark contrast to the wt AsqJ for which we observe the product peak with maximum intensity after 30 min (Fig. 4). In contrast, the F139I mutant only displays a minor increase in activity, whereas the turnover of V72K for 1d is similar to the wt enzyme as proposed by our MD simulations (Supplementary Fig. 14). Notably, formation of the epoxide 3d was not observed for the designed mutant V72I, implying that the mutated enzyme is capable of activating C–H bonds of 1d, while it cannot effectively proceed into the second part of the reaction cycle. On the other hand, starting with the synthesized desaturated intermediate 2 of the methylated natural substrate 1, the activity assays show similar turnover for the wt AsqJ and the V72I variant (Supplementary Fig. 13c, d). These results led us to conclude that the substrate methylation is also a fundamental prerequisite for the epoxidation reaction. These findings are supported by the QM/MM MD simulations, which indicate that stabilization of the non-methylated reaction intermediate 2d inside the V72I variant is rather weak (Supplementary Fig. 15). Therefore, the following epoxidation, which further requires binding and activation of a new oxygen molecule and release of CO2, is prevented since the residence time of 2d at the active center is probably far too short to successfully complete the oxidoreduction. However, elucidating the molecular principles for these steps and engineering an enzyme that would further catalyze the epoxidation reaction is outside the scope of the present work.

Fig. 4
Fig. 4

Activity measurements of wt and engineered AsqJ. Turnover of the wt and V72I-mutated AsqJ for the non-methylated substrate analog (1d) from reverse-phase HPLC/MS-coupled activity assays in the presence of FeII, αKG, oxygen, and ascorbic acid. The absorbance at λ = 280 nm is shown for 1d and the desaturated reaction intermediate 2d (see Supplementary Fig. 13 for further characterization). The reaction progress was analyzed after 20 s (black trace), 1 min (dark blue), 2 min (light blue), 5 min (dark green), 10 min (light green), and 30 min (orange), showing that 2d forms already after 20 s in V72I

Experimental structural insight into the function of AsqJ_V72I was obtained by crystallographically analyzing the mutant in complex with 1 (1.55 Å resolution, RFree = 16.8%), 1b (1.65 Å, RFree = 17.4%), and 1d (1.75 Å, RFree = 19.3%), as well as determining the structure of V72K bound to 1b (1.55 Å resolution, Rfree = 19.4%, PDB ID 6EOZ). Our calculations predict that stabilization of these ligands in the active site depends on pronounced π-stacking interactions, which are most important for the initiation of the PCET reactions. Interestingly, the crystal structure of V72I in presence of 1d reveals that the distance between Ile-72 and C4′ of the non-methylated analog is decreased by 0.2 Å compared to wt AsqJ:1d complex (PDB ID 5DAX, Fig. 5). Notably, despite the local conformational changes at the active site, all other parts of the mutant structure remain unchanged with a root-mean square deviation (RMSD) of 0.15 Å for the protein backbone atoms. These experimental insights perfectly match to our initial computational refinements (see above). Moreover, a close inspection of the electron density map depicts an alternative conformation rotation of the Ile-72-side chain, positioning the introduced isobutyl group in an inward and outward orientation (Fig. 4). In addition, the B-factor of 1d is increased from 28.7 (AsqJ-wt) to 35.3 Å2 (AsqJ-V72I) (Supplementary Table 3, Supplementary Fig. 16). This observation accounts for an improved mobility of the phenyl group of 1d around the C3–C1″ bond in the AsqJ_V72I, and is caused by the two alternative conformations of Ile-72. Consistently, an extra lobe of electron density around the phenyl ring of 1d in the AsqJ_V72I structure indicates that the aromatic moiety of the ligand is quite flexible (Fig. 5a). Thus, our findings suggest that the stable π-stacking interactions of 1d with His-134 lead to a prolonged residence time of the ligand at the active site, facilitating the desaturation reaction. Taken together, our findings suggest that substrate binding in AsqJ is linked with a conformational rearrangement of the residues in the loop surrounding the specificity pocket, and stabilization of the different conformational states might provide a promising starting point for future studies to rationally engineer AsqJ to catalyze the turnover of modified substrates.

Fig. 5
Fig. 5

Crystal structure of the AsqJ_V72I mutant. a) Close-up of the active site in complex with 1d (shown in green). The amino acids engaged in ligand binding are depicted as sticks and labeled by the one letter code, α-ketoglutarate (αKG) shown in orange, and NiII is shown as a black sphere. The electron density depicts a 2FoFc map with I72, H134, and 1d omitted for phasing. I72 contains two alternative conformations with an occupancy of ~50% (PDB ID: 5OA8). An extra lobe of electron density around the phenyl ring of 1d indicates increased mobility of the phenyl ring. b Structure of the active site superposition of AsqJ_V72I:1d with the wt AsqJ:1d (shown in gray; PDB ID: 5DAX). π-stacking and coordination of the metal atom are indicated by black-dotted lines. Note that the surrogate 1d adopts identical positions in both crystal structures, while there are only marginal shifts in the distances of I72 coordinating the aromatic moiety of the ligand

In conclusion, the molecular mechanism of an exceptional one-pot multistep dioxygenase AsqJ from A. nidulans was studied by combined molecular simulations, biochemical in vitro activity assays, mutagenesis, and X-ray crystallography. The enzyme catalyzes a stepwise desaturation and epoxidation reaction of 4′-methoxycyclopeptin to the quinolone alkaloid, 4′-methoxyviridicatin by highly exergonic and kinetically feasible proton-coupled transfer PCET reactions. We observed that methylation of the substrate at the N4 position is important for stabilizing dispersive interactions within the active site during the PCET processes. Combining various orthogonal methodologies such as multi-scale computational chemistry, mutagenesis, in vitro activity assays, and protein crystallography, revealed that an engineered AsqJ_V72I mutant is able to rapidly catalyze desaturation of the non-methylated surrogate, which is in stark contrast to wt AsqJ. We could show that the smallest possible V72I replacement in a loop surrounding the active site drastically improved turnover of demethylcyclopeptin 1d, and that insertion of one methyl group to the protein compensates for the lack of one N-methyl group in the substrate. In conclusion, the achieved results provide an important starting point to understand molecular mechanisms of multifunctional enzymes, and to rationally engineer such systems for the synthesis of natural products with important biomedical applications.

Methods

DFT models

Quantum chemical DFT cluster models with 190–194 atoms were constructed based on our recently crystallized NiII-substituted model of AsqJ (PDB ID: 5DAQ)2. The QM models comprised in addition to the iron-oxo species the substrate, αKG (or CO2 + succinate), two crystal water molecules, and amino acid residues Asn-70, Met-118, Gln-131, His-134, Asp-136, Asn-157, Leu-159, Ile-205, His-211, Arg-223, and Thr-227 (Fig. 1a, inset). We note that, inclusion of Val-72 in the QM models did not considerably change the relative energies between the reaction intermediates (Supplementary Table 1). The amino acids were cut between the Cα and Cβ atoms, except for Asn-70, Thr-227, and Arg-223, which were cut between Cβ/Cγ and Cγ/Cδ atoms, respectively. We also included the backbone of residues Pro-132/Leu-133 and Thr-209/Ile-210. The terminal carbon atoms were saturated with hydrogen atoms, and fixed during structure optimization to account for steric effects of the protein environment (Fig. 1a, inset). Geometry optimizations were performed at dispersion-corrected DFT level24, using the B3LYP-D3 functional25,26, and def2-SVP (light elements) and def2-TZVP basis sets (Fe). The protein surroundings were treated as a polarizable medium with a dielectric constant of ε = 4 using the COSMO model27,28. Reaction pathways were optimized using the Woelfling method29, a chain-of-states method that is related to the nudged-elastic band30 and zero-temperature string methods31. The final energetics for all states were computed at the B3LYP-D3/def2-TZVP/ε = 4 level, and electronic configurations were analyzed from Mulliken populations and spin density distributions. The reaction pathways were optimized for both the triplet and quintet spin states, as also supported by recent computational studies suggesting that several spin states may contribute in the catalysis steps of AsqJ15,16. The absolute electronic energies for the quintet states were ca. 5–10 kcal mol−1 more stable than for the triplet states, whereas the structural and relative energy differences between the states were marginal. Vibrational and entropic corrections were obtained at the B3LYP-D3/def2-SV(P)/ε = 4 level by estimating the molecular Hessian numerically32. Furthermore, we studied the isolated substrate in different states by both complete and restrained optimizations at the B3LYP-D3/def2-SVP level. Strain energies were obtained from restrained optimizations of the relaxed substrates to their protein geometries. All distances and free energies discussed in the main text and shown in the figures were extracted from the optimized QM models. All QM calculations were performed using TURBOMOLE v. 6.633, and non-covalent interaction regions were calculated using NCIPLOT34.


Combined quantum mechanical and molecular mechanical methods

Hybrid QM/MM MD simulations of AsqJ with the substrate with and without the methyl group at the N4 position, prior and after the first PCET reaction, were performed at the B3LYP-D3/CHARMM3635 level using def2-SVP (light elements) and def2-TZVP (Fe) basis sets. The QM region comprised protein residues His-134, Asp-136 and His-211, the succinate/CO2 moiety, in addition to the ferryl (FeIV = O2-) or ferric (FeIII–OH) metal center and the substrate. Link atoms were introduced between the Cβ and Cα atoms of the protein residues, and the monomeric protein model was embedded in a water box with 18,089 water molecules, and neutralized by 100 mM NaCl. The complete QM/MM system, comprising 58,896 atoms, was simulated for 3 ps for each state at T = 310 K, and by using a 1 fs integration time step. No positional restrains were applied in the QM/MM MD simulations. All QM/MM calculations were performed using TURBOMOLE v. 6.6 linked together with CHARMM36,37.


Classical MD simulations

Classical MD simulations of the wt and V72I, V72K, and F139I in silico mutants were performed for 15 ns at T = 310 K using a 1 fs time step, and treating the long-range electrostatics using the Particle Mesh Ewald (PME) approach38. We employed the CHARMM36 force field, together with force field parameters for the active site models based on CGenFF39 and by calculated restrained electrostatic potential (RESP) charges for the substrates and small active site models at the B3LYP/def2-TZVP level obtained with NWChem40. Classical MD simulations were performed using NAMD41, and visual molecular dynamics was used for visualization analysis42.


Site-directed mutagenesis experiments and protein purification

Mutations in the wt asqJ gene of the fungus A. nidulans FGSC A4 (pET28bSUMOAnAsqJ, GenBank: XP_682496.1)2 were introduced via the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies) using oligonucleotides listed in Supplementary Table 2. Bacterial culture and protein purification were performed according to published procedures2. The protein solutions were buffer exchanged to 20 mM Tris hydrochloride, pH 7.4, containing 100 mM NaCl and 2 mM dithiothreitol, and were concentrated to a concentration of 20 mg/mL using a 10k Amicon Ultra Centrifugal Filter Device (Millipore, Billerica, MA), flash frozen with liquid nitrogen and stored at −80 °C.


HPLC/MS experiments

Reaction mixtures containing 33 µM purified AsqJ_wt (AsqJ_V72I, AsqJ_V72K, or, AsqJ_F139I), 200 µM of the synthesized substrate2, 100 µM FeSO4, 2.5 mM α-ketoglutarate, 4 mM ascorbic acid, and 50 mM Tris hydrochloride were incubated at 30 °C for 20 s, 1 min, 2 min, 5 min, 10 min, 30 min, and 60 min. The reaction was stopped by adding 10% (v/v) of 3 M trichloroacetic acid, and samples were centrifuged at 10,000 ×  g for 10 min. All traces were monitored at 280 nm using a Dionex UltiMate 3000 HPLC system coupled with a Thermo LCQ fleet in combination with a Waters 1525 binary HPLC pump, X-Bridge Prep C18 column (5 µm, 10 × 250 mm), Waters 2998 PDA detector and Waters Fraction Collector III (Waters).


X-ray crystallography

Mutant AsqJ proteins were crystallized as previously described for the wt AsqJ2. Crystals were grown at 20 °C using the sitting drop vapor diffusion method. Drops contained a 1:1 mixture of protein solution (20 mg ml−1 protein, 1 mM α-ketoglutarate as well 2 mM 1, 1b, or 1d) and reservoir solution (100 mM Tris hydrochloride, pH 7.8–8.2, 1.0 M LiBr, 27–30% PEG6000). Crystals were cryoprotected by addition of cryobuffer (100 mM Tris hydrochloride, pH 7.8, 500 mM LiBr, 30% PEG400). Diffraction data were collected at the beamline X06SA at the Paul Scherrer Institute, SLS, Villigen, Switzerland (λ = 1.0Å). Evaluation of reflection intensities and data reduction were performed with the program package XDS43. Positioning of the initial model was carried out with the coordinates of the AsqJ_wt (PDB ID: 5DAQ) by rigid body refinements (REFMAC544). MAIN45 and COOT46 were used to build models. TLS (Translation/Libration/Screw) refinements finally yielded excellent Rwork and Rfree, as well as RMSD bond and angle values (Supplementary Table 3). Note, the asymmetric unit of the crystals contains one subunit, which by crystallographic symmetry forms the physiological dimer, with two identical active sites.


Data availability

The coordinates, proven to have good stereochemistry from the Ramachandran plots, were deposited at the RCSB Protein Data Bank under the accession codes 5OA4 (AsqJ_V72I:1), 5OA7 (AsqJ_V72I:1b), 5OA8 (AsqJ_V72I:1d), and 6EOZ (AsqJ_V72K:1b). All other data is available from the authors upon reasonable request.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Ishikawa, N. et al. Non-heme dioxygenase catalyzes atypical oxidations of 6,7-bicyclic systems to form the 6,6-quinolone core of viridicatin-type fungal alkaloids. Angew. Chem. Int. Ed. 53, 12880–12884 (2014).

  2. 2.

    Bräuer, A., Beck, P., Hintermann, L. & Groll, M. Structure of the dioxygenase AsqJ: mechanistic insights into a one-pot multistep quinolone antibiotic biosynthesis. Angew. Chem. Int. Ed. 55, 422–426 (2016).

  3. 3.

    Scherlach, K. & Hertweck, C. Discovery of aspoquinolones A-D, prenylated quinoline-2-one alkaloids from Aspergillus nidulans, motivated by genome mining. Org. Biomol. Chem. 4, 3517–3520 (2006).

  4. 4.

    Uchida, R. et al. Yaequinolones, new insecticidal antibiotics produced by Penicillium sp. FKI-2140. J. Antibiot. 59, 646–651 (2006).

  5. 5.

    An, C.-Y. et al. 4-Phenyl-3,4-dihydroquinolone derivatives from Aspergillus nidulans MA-143, an endophytic fungus isolated from the mangrove plant Rhizophora stylosa. J. Nat. Prod. 76, 1896–1901 (2013).

  6. 6.

    Ahmed, A. & Daneshtalab, M. Nonclassical biological activities of quinolone derivatives. J. Pharm. Pharm. Sci. 15, 52–72 (2012).

  7. 7.

    Hausinger, R. P. Fe(II)/α-ketoglutarate-dependent hydroxylases and related enzymes. Crit. Rev. Biochem. Mol. Biol. 39, 21–68 (2004).

  8. 8.

    Müller, I. et al. Crystal structure of the alkylsulfatase AtsK: insights into the catalytic mechanism of the Fe(II) α-ketoglutarate-dependent dioxygenase superfamily. Biochemistry 43, 3075–3088 (2004).

  9. 9.

    Flashman, E. & Schofield, C. J. The most versatile of all reactive intermediates? Nat. Chem. Biol. 3, 86–87 (2007).

  10. 10.

    Krebs, C., Fujimori, D. G., Walsh, C. T. & Bollinger, J. M. Jr. Non-heme Fe(IV)-oxo intermediates. Acc. Chem. Res. 40, 484–492 (2007).

  11. 11.

    Bugg, T. D. H. Oxygenases: mechanisms and structural motifs for O2 activation. Curr. Opin. Chem. Biol. 5, 550–555 (2001).

  12. 12.

    Price, J. C., Barr, E. W., Glass, T. E., Krebs, C. & Bollinger, J. M. Jr. Evidence for hydrogen abstraction from C1 of taurine by the high-spin Fe(IV) intermediate detected during oxygen activation by taurine:α-ketoglutarate dioxygenase (TauD). J. Am. Chem. Soc. 125, 13008–13009 (2003).

  13. 13.

    Bugg, T. D. H. Dioxygenase enzymes: catalytic mechanisms and chemical models. Tetrahedron 59, 7075–7101 (2003).

  14. 14.

    Chang, W., Li, J., Lee, J. L., Cronican, A. A. & Guo, Y. Mechanistic investigation of a non-heme iron enzyme catalyzed epoxidation in (–)-4’-methoxycyclopenin biosynthesis. J. Am. Chem. Soc. 138, 10390–10393 (2016).

  15. 15.

    Song, X., Lu, J. & Lai, W. Mechanistic insights into dioxygen activation, oxygen atom exchange and substrate epoxidation by AsqJ dioxygenase from quantum mechanical/molecular mechanical calculations. Phys. Chem. Chem. Phys. 19, 20188–20197 (2017).

  16. 16.

    Su, H., Sheng, X., Zhu, W., Ma, G. & Liu, Y. Mechanistic insights into the decoupled desaturation and epoxidation catalyzed by dioxygenase AsqJ involved in the biosynthesis of quinolone alkaloids. ACS Catal. 7, 5534–5543 (2017).

  17. 17.

    Walsh, C. T., Haynes, S. W., Ames, B. D., Gao, X. & Tang, Y. Short pathways to complexity generation: fungal peptidyl alkaloid multicyclic scaffolds from anthranilate building blocks. ACS Chem. Biol. 8, 1366–1382 (2013).

  18. 18.

    Supekar, S., Gamiz-Hernandez, A. P. & Kaila, V. R. I. A protonated water cluster as a transient proton-loading site in cytochrome c oxidase. Angew. Chem. Int. Ed. 55, 11940–11944 (2016).

  19. 19.

    Ugur, I., Rutherford, A. W. & Kaila, V. R. I. Redox-coupled substrate water reorganization in the active site of photosystem II—the role of calcium in substrate water delivery. Biochim Biophys Acta 1857, 740–748 (2016).

  20. 20.

    Sharma, V. et al. Redox-induced activation of the proton pump in the respiratory complex I. Proc. Natl Acad. Sci. USA 112, 11571–11576 (2015).

  21. 21.

    Luo, Q., Boczek, E. E., Wang, Q., Buchner, J. & Kaila, V. R. I. Hsp90 dependence of a kinase is determined by its conformational landscape. Sci. Rep. 7, 43996 (2017).

  22. 22.

    Solomon, E. I. et al. Geometric and electronic structure/function correlations in non-heme iron enzymes. Chem. Rev. 100, 235–349 (2000).

  23. 23.

    Sahu, S. & Goldberg, D. P. Activation of dioxygen by iron and manganese complexes: a heme and nonheme perspective. J. Am. Chem. Soc. 138, 11410–11428 (2016).

  24. 24.

    Grimme, S., Antony, J., Ehrlich, S. & Krieg, H. A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. J. Chem. Phys. 132, 154104 (2010).

  25. 25.

    Becke, A. D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 98, 5648–5652 (1993).

  26. 26.

    Lee, C., Yang, W. & Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B 37, 785–789 (1988).

  27. 27.

    Klamt, A. & Schüürmann, G. COSMO: a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient. J. Chem. Soc. Perkin Trans. 2, 799–805 (1993).

  28. 28.

    Schäfer, A., Klamt, A., Sattel, D., Lohrenz, J. C. W. & Eckert, F. COSMO implementation in TURBOMOLE: extension of an efficient quantum chemical code towards liquid systems. Phys. Chem. Chem. Phys. 2, 2187–2193 (2000).

  29. 29.

    Plessow, P. Reaction path optimization without NEB springs or interpolation algorithms. J. Chem. Theory Comput. 9, 1305–1310 (2013).

  30. 30.

    Henkelman, G. & Jόnsson, H. Improved tangent estimate in the nudged elastic band method for finding minimum energy paths and saddle points. J. Chem. Phys. 113, 9978–9985 (2000).

  31. 31.

    Weinan, E., Ren, W. & Vanden-Eijnden, E. String method for the study of rare events. Phys. Rev. B 66, 052301 (2002).

  32. 32.

    Deglmann, P. & Furche, F. Efficient characterization of stationary points on potential energy surfaces. J. Chem. Phys. 117, 9535–9538 (2002).

  33. 33.

    Ahlrichs, R., Bär, M., Häser, M., Horn, H. & Kölmel, C. Electronic structure calculations on workstation computers: the program system turbomole. Chem. Phys. Lett. 162, 165–169 (1989).

  34. 34.

    Contreras-García, J. et al. NCIPLOT: a program for plotting noncovalent interaction regions. J. Chem. Theory Comput. 7, 625–632 (2011).

  35. 35.

    Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ1 and χ2 dihedral angles. J. Chem. Theory Comput. 8, 3257–3273 (2012).

  36. 36.

    Brooks, B. R. et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 30, 1545–1614 (2009).

  37. 37.

    Riahi, S. & Rowley, C. N. The CHARMM-TURBOMOLE interface for efficient and accurate QM/MM molecular dynamics, free energies, and excited state properties. J. Comput. Chem. 35, 2076–2086 (2014).

  38. 38.

    Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577–8593 (1995).

  39. 39.

    Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671–690 (2010).

  40. 40.

    Valiev, M. et al. NWChem: a comprehensive and scalable open-source solution for large scale molecular simulations. Comput. Phys. Commun. 181, 1477–1489 (2010).

  41. 41.

    Phillips, J. C. et al. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781–1802 (2005).

  42. 42.

    Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).

  43. 43.

    Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).

  44. 44.

    Vagin, A. A. et al. REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr. D Biol. Crystallogr. 60, 2184–2195 (2004).

  45. 45.

    Turk, D. MAIN software for density averaging, model building, structure refinement and validation. Acta Crystallogr. D Biol. Crystallogr. 69, 1342–1357 (2013).

  46. 46.

    Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).

Download references

Acknowledgements

This work was supported by the German Research Foundation (SFB1035 project B12 to V.R.I.K., SFB749 to M.G.) and by the 1974-01 TUM-KAUST agreement on selective C–H bond activation (A.B.). The authors are thankful for the computing time provided by the Leibniz Rechenzentrum. We thank the staff of the beamline X06SA at the Paul Scherrer Institute, SLS, Villigen (Switzerland) for assistance during data collection.

Author information

Author notes

  1. These authors contributed equally: Sophie L. Mader, Alois Bräuer.

Affiliations

  1. Center for Integrated Protein Science Munich (CIPSM), Department Chemie, Technische Universität München, Lichtenbergstraße 4, 85748, Garching, Germany

    • Sophie L. Mader
    • , Alois Bräuer
    • , Michael Groll
    •  & Ville R. I. Kaila

Authors

  1. Search for Sophie L. Mader in:

  2. Search for Alois Bräuer in:

  3. Search for Michael Groll in:

  4. Search for Ville R. I. Kaila in:

Contributions

V.R.I.K. and M.G. designed the project; S.L.M. and V.R.I.K. performed and analyzed all calculations; A.B. created mutants, purified proteins, and performed activity assays; A.B. and M.G. collected and analyzed X-ray data; V.R.I.K. and M.G. wrote the manuscript, with contributions from all authors.

Competing interests

The authors declare no competing interests.

Corresponding authors

Correspondence to Michael Groll or Ville R. I. Kaila.

Electronic supplementary material

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41467-018-03442-2

Rights and permissions

Creative Commons BY

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.